Reckitt Benckiser Group plc (LON:RKT)

Market Cap	36.02B
Revenue (ttm)	14.33B
Net Income (ttm)	1.54B
Shares Out	684.57M
EPS (ttm)	2.16
PE Ratio	24.34
Forward PE	16.02
Dividend	1.96 (3.71%)
Ex-Dividend Date	n/a

Volume	1,215,618
Average Volume	1,584,734
Open	5,294.00
Previous Close	5,286.00
Day's Range	5,250.00 - 5,302.00
52-Week Range	4,034.00 - 5,886.44
Beta	0.12
RSI	58.55
Earnings Date	Mar 6, 2025

About Reckitt Benckiser Group

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet bra...

• Industry: Household & Personal Products
• Sector: Consumer Staples
• Founded: 1819
• Employees: 40,000
• Stock Exchange: London Stock Exchange
• Ticker Symbol: RKT

Financial Performance

In 2023, Reckitt Benckiser Group's revenue was 14.61 billion, an increase of 1.07% compared to the previous year's 14.45 billion. Earnings were 1.64 billion, a decrease of -29.48%.